Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia.
about
Cellular immunotherapy for pediatric solid tumorsStimulating antitumor immunity with nanoparticlesHeating the patient: a promising approach?The Kadota Fund International Forum 2004--clinical group consensus.Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.Temperature-dependent and time-dependent effects of hyperthermia mediated by dextran-coated La0.7Sr0.3MnO3: in vitro studiesAntibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivoImmunotherapy for malignant glioma: current approaches and future directions.Current immunotherapeutic strategies for central nervous system tumors.Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses.Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress.Optimizing magnetic nanoparticle design for nanothermotherapy.Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.Abscopal antitumor immune effects of magnet-mediated hyperthermia at a high therapeutic temperature on Walker-256 carcinosarcomas in rats.Tumour infiltrating host cells and their significance for hyperthermia.Medulloblasoma: challenges for effective immunotherapy.Various ways to improve whole cancer cell vaccines.Stimuli-responsive cancer therapy based on nanoparticles.Screening of stress enhancer based on analysis of gene expression profiles: enhancement of hyperthermia-induced tumor necrosis by an MMP-3 inhibitor.Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours.Increased immunogenicity is an integral part of the heat shock response following renal ischemia.Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia.Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and TherapyImmunologic response induced by synergistic effect of alternating cooling and heating of breast cancer.In-Vitro Investigations of Nanoparticle Magnetic Thermotherapy: Adjuvant Effects and Comparison to Conventional Heating.Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles.Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles.Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors.4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumor immunogenicity.
P2860
Q27014912-4F8D6F0F-08D6-47CD-93B1-113EE8A989F6Q27027780-D9FD098B-1285-4BAF-8C36-07D22D59F8F5Q33184112-EDD6143A-706D-46B4-BB52-CA895E9FF1B7Q33320286-3947240D-AD8E-4DD3-8E9D-06DA91A66D7FQ34208635-5B2F8324-AD20-4AC5-844E-2C629E298E9DQ35137269-DA5B109C-6999-40A8-BC9D-66D36E2159D0Q35298302-9BFB4D79-F0B5-46BD-B535-FD810229E9E5Q36273693-0A09DE12-EC5B-4254-9C65-09C42EF0E51AQ36325239-7E813E62-7704-493E-BCA2-E3967D9E25C4Q37030810-B1AE923A-4F6F-486C-9072-EAAEF17FFA35Q37063492-59FC1FC5-AF0B-4991-A04A-BD658743C4B0Q37063499-566CCCC7-2831-4F3E-99BD-957D380CA301Q37331799-332C38F6-31A0-435E-86A8-9C6152890703Q37383547-8261C988-F04D-43FB-B231-53BEE639A8EBQ37575037-006A696D-F8B3-4319-BDB1-619183448AB5Q37730088-16BD6DB4-3750-4EF6-977A-0D1094B4EFBDQ37968929-622CF668-88FF-445A-9377-6B78BAD9A4EAQ38206582-6B0B8F84-99EE-4C96-986D-2C4B3390F644Q38233457-95B2590C-9F1E-415A-874E-0A42DC259899Q38352950-BC89F263-08EF-4A26-9B0F-567E01AD88C2Q38601773-82371263-2C30-462E-8410-0DBA527C98BDQ39425915-DA086CBA-1AD1-4B27-BDEE-9AAE359D7702Q39440624-3170344A-81CD-4A41-B5E0-679A737D1C02Q39829640-2DD5CE05-D44E-4B38-A20D-4AE85D0A6CF0Q40002350-456921D7-55DA-404F-82C4-AD5377F2304BQ42138582-828DB11E-5831-4F2B-AABA-3DAA9A0BB679Q42176403-A43C7EE2-4C5E-48DE-8E91-533F58A4B4F6Q45871523-3AAB2C99-8F98-4994-A49B-8819AE7A4C50Q46614619-13DABC61-D164-41CD-BDA6-EF356083934AQ51075611-FA820136-3755-4414-93D2-61B75BCE2421Q51747472-01C733B1-3250-4F29-8EBE-0DCAA3E1049B
P2860
Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Augmentation of MHC class I an ...... in expression by hyperthermia.
@en
Augmentation of MHC class I an ...... in expression by hyperthermia.
@nl
type
label
Augmentation of MHC class I an ...... in expression by hyperthermia.
@en
Augmentation of MHC class I an ...... in expression by hyperthermia.
@nl
prefLabel
Augmentation of MHC class I an ...... in expression by hyperthermia.
@en
Augmentation of MHC class I an ...... in expression by hyperthermia.
@nl
P2093
P1476
Augmentation of MHC class I an ...... in expression by hyperthermia.
@en
P2093
P2888
P304
P356
10.1007/S00262-001-0233-7
P577
2001-12-01T00:00:00Z
P6179
1002588042